Logo image of CHS

Chicos FAS Inc (CHS) Stock Fundamental Analysis

NYSE:CHS - New York Stock Exchange, Inc. - US1686151028 - Common Stock - Currency: USD

7.59  -0.01 (-0.13%)

After market: 7.591 +0 (+0.01%)

Fundamental Rating

5

Overall CHS gets a fundamental rating of 5 out of 10. We evaluated CHS against 120 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CHS get a neutral evaluation. Nothing too spectacular is happening here. CHS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CHS had positive earnings in the past year.
CHS had a positive operating cash flow in the past year.
In multiple years CHS reported negative net income over the last 5 years.
CHS had a positive operating cash flow in 4 of the past 5 years.
CHS Yearly Net Income VS EBIT VS OCF VS FCFCHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

CHS has a Return On Assets of 8.82%. This is in the better half of the industry: CHS outperforms 79.84% of its industry peers.
CHS has a Return On Equity of 26.40%. This is in the better half of the industry: CHS outperforms 79.84% of its industry peers.
With a decent Return On Invested Capital value of 12.31%, CHS is doing good in the industry, outperforming 77.52% of the companies in the same industry.
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROIC 12.31%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
CHS Yearly ROA, ROE, ROICCHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

CHS has a better Profit Margin (5.29%) than 72.87% of its industry peers.
CHS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 6.16%, CHS is in the better half of the industry, outperforming 68.22% of the companies in the same industry.
In the last couple of years the Operating Margin of CHS has grown nicely.
CHS has a Gross Margin of 38.94%. This is comparable to the rest of the industry: CHS outperforms 59.69% of its industry peers.
In the last couple of years the Gross Margin of CHS has remained more or less at the same level.
Industry RankSector Rank
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
CHS Yearly Profit, Operating, Gross MarginsCHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHS is creating some value.
The number of shares outstanding for CHS has been increased compared to 1 year ago.
CHS has less shares outstanding than it did 5 years ago.
CHS has a better debt/assets ratio than last year.
CHS Yearly Shares OutstandingCHS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
CHS Yearly Total Debt VS Total AssetsCHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.22 indicates that CHS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.22, CHS is in the better half of the industry, outperforming 70.54% of the companies in the same industry.
The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
CHS has a Debt to FCF ratio of 0.42. This is amongst the best in the industry. CHS outperforms 82.17% of its industry peers.
CHS has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.06, CHS is doing good in the industry, outperforming 75.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Altman-Z 3.22
ROIC/WACC1.34
WACC9.19%
CHS Yearly LT Debt VS Equity VS FCFCHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.20, CHS is doing worse than 72.09% of the companies in the same industry.
CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.42, CHS is doing worse than 60.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.42
CHS Yearly Current Assets VS Current LiabilitesCHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CHS have decreased strongly by -15.38% in the last year.
Measured over the past 5 years, CHS shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
CHS shows a decrease in Revenue. In the last year, the revenue decreased by -0.24%.
The Revenue has been decreasing by -1.26% on average over the past years.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%

3.2 Future

Based on estimates for the next years, CHS will show a decrease in Earnings Per Share. The EPS will decrease by -8.47% on average per year.
The Revenue is expected to grow by 0.60% on average over the next years.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHS Yearly Revenue VS EstimatesCHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CHS Yearly EPS VS EstimatesCHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.86, the valuation of CHS can be described as reasonable.
Based on the Price/Earnings ratio, CHS is valued a bit cheaper than 79.07% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. CHS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 10.29, which indicates a very decent valuation of CHS.
Based on the Price/Forward Earnings ratio, CHS is valued a bit cheaper than the industry average as 74.42% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CHS to the average of the S&P500 Index (22.68), we can say CHS is valued rather cheaply.
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
CHS Price Earnings VS Forward Price EarningsCHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHS is valued cheaper than 85.27% of the companies in the same industry.
67.44% of the companies in the same industry are more expensive than CHS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 4.72
CHS Per share dataCHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of CHS may justify a higher PE ratio.
CHS's earnings are expected to decrease with -8.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Chicos FAS Inc

NYSE:CHS (1/4/2024, 8:04:00 PM)

After market: 7.591 +0 (+0.01%)

7.59

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-30 2023-11-30/bmo
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
P/S 0.44
P/FCF 16.37
P/OCF 8.25
P/B 2.22
P/tB 2.34
EV/EBITDA 4.72
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROCE 15.79%
ROIC 12.31%
ROICexc 14.55%
ROICexgc 15.01%
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
FCFM 2.71%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Debt/EBITDA 0.14
Cap/Depr 134.65%
Cap/Sales 2.67%
Interest Coverage 35.98
Cash Conversion 66.14%
Profit Quality 51.32%
Current Ratio 1.2
Quick Ratio 0.42
Altman-Z 3.22
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%